Bill Moyers: The Corporate Plot That Obama and Corporate Lobbyists Don't Want You to Know About
By Bill Moyers, Yves Smith, Dean Baker
November 1, 2013
| A US-led trade deal is currently being negotiated that could
increase the price of prescription drugs, weaken financial regulations
and even allow partner countries to challenge American laws. But few
know its substance.
And some vigilant independent watchdogs are tracking the negotiations with sources they trust, including Dean Baker and Yves Smith, who join Moyers & Company this week. Both have written extensively about the TPP and tell Bill the pact actually has very little to do with free trade.
No comments:
Post a Comment